Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Zoetis Inc. logo

Zoetis Inc. (ZTS) Stock Ticker

NYSE: ZTS · Healthcare · Drug Manufacturers - Specialty & Generic
$71.43+1.11%
USD · as of 2026-09-29 · market cap $29.8B
Open ZTS in TickrRead the ZTS AI analysisDownload for iPhone

ZTS right now

Valuation vs its own historyCheap · bottom 1%
Options expect by Oct 6±6.2%
Options expect by Oct 29±12.7%
Priced in for Nov 5 earnings±14.1%
IV rank (30-day)73% · rich
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full ZTS picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on ZTS
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Zoetis Inc.

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

ZTS stock facts

Ticker symbolZTS
ExchangeNew York Stock Exchange
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$29.8B
CEOKristin C. Peck
Employees14,500
HeadquartersParsippany, NJ, US
IPO date2013-02-01
Websitewww.zoetis.com

What you can see for ZTS on Tickr

Live ZTS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ZTS report.

Rankings

Largest Healthcare companiesLargest companies by market cap

ZTS peers

ARGXBDXCICORELANELVHLNIDXX

FAQ

What is the ticker symbol for Zoetis Inc.?

The ticker symbol for Zoetis Inc. is ZTS, listed on the New York Stock Exchange.

What is ZTS?

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and…

HomeExploreMarketLists
All pages